4NWK - Header Asymmetric Unit

HEADER HYDROLASE/HYDROLASE INHIBITOR 06-DEC-13 4NWK

TITLE CRYSTAL STRUCTURE OF HEPATIS C VIRUS PROTEASE (NS3) COMPLEXED WITH TITLE 2 BMS-605339 AKA N-(TERT-BUTOXYCARBONYL)-3-ME THYL-L-VALYL-(4R)-N-((1R, TITLE 3 2S)-1-((CYCLOPROPYLSULFONYL)CARBA MOYL)-2-VINYLCYCLOPROPYL)-4-((6- TITLE 4 METHOXY-1-ISOQUINOLINYL)OX Y)-L-PROLINAMIDE

COMPND MOL_ID: 1; COMPND 2 MOLECULE: HCV NS3 1A PROTEASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: THE PROTEIN CRYSTALLIZED IS A SINGLE-CHAIN CONSTRUCT COMPND 6 OF PROTEASE DOMAIN OF HEPATITIS C VIRUS NS3/4A, WITH COFACTOR 4A COMPND 7 COVALENTLY LINKED AT THE N-TERMINUS.

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS; SOURCE 3 ORGANISM_TAXID: 31646; SOURCE 4 STRAIN: 1A; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562

KEYWDS HYDROLASE/HYDROLASE INHIBITOR, SERINE PROTEASE, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX

EXPDTA X-RAY DIFFRACTION

AUTHOR J.K.MUCKELBAUER,H.E.KLEI

REVDAT 1 26-MAR-14 4NWK 0

JRNL AUTH P.M.SCOLA,A.X.WANG,A.C.GOOD,L.Q.SUN,K.D.COMBRINK, JRNL AUTH 2 J.A.CAMPBELL,J.CHEN,Y.TU,N.SIN,B.L.VENABLES,S.Y.SIT,Y.CHEN, JRNL AUTH 3 A.COCUZZA,D.M.BILDER,S.D'ANDREA,B.ZHENG,P.HEWAWASAM,M.DING, JRNL AUTH 4 J.THURING,J.LI,D.HERNANDEZ,F.YU,P.FALK,G.ZHAI,A.K.SHEAFFER, JRNL AUTH 5 C.CHEN,M.S.LEE,D.BARRY,J.O.KNIPE,W.LI,Y.H.HAN,S.JENKINS, JRNL AUTH 6 C.GESENBERG,Q.GAO,M.W.SINZ,K.S.SANTONE,T.ZVYAGA,R.RAJAMANI, JRNL AUTH 7 H.E.KLEI,R.J.COLONNO,D.M.GRASELA,E.HUGHES,C.CHIEN,S.ADAMS, JRNL AUTH 8 P.C.LEVESQUE,D.LI,J.ZHU,N.A.MEANWELL,F.MCPHEE JRNL TITL DISCOVERY AND EARLY CLINICAL EVALUATION OF BMS-605339, A JRNL TITL 2 POTENT AND ORALLY EFFICACIOUS TRIPEPTIDIC ACYLSULFONAMIDE JRNL TITL 3 NS3 PROTEASE INHIBITOR FOR THE TREATMENT OF HEPATITIS C JRNL TITL 4 VIRUS INFECTION. JRNL REF J.MED.CHEM. V. 57 1708 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 24555570 JRNL DOI 10.1021/JM401840S

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH H.E.KLEI,K.KISH,M.F.RUSSO,S.J.MICHALCZYK,M.H.CAHN,J.TREDUP, REMARK 1 AUTH 2 C.CHANG,J.KHAN,E.T.BALDWIN REMARK 1 TITL IMAGE ANNOTATION AND DATABASE MINING TO CREATE A NOVEL REMARK 1 TITL 2 SCREEN FOR THE CHEMOTYPE-DEPENDENT CRYSTALLIZATION OF HCV REMARK 1 TITL 3 NS3 PROTEASE REMARK 1 REF CRYST. GROWTH AND DES. V. 11 1143 2011

REMARK 2 REMARK 2 RESOLUTION. 1.62 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 480513.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 26144 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1017 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.1990 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1980 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 3.900 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1023 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0070 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 26331 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.67 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 61.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1973 REMARK 3 BIN R VALUE (WORKING SET) : 0.2270 REMARK 3 BIN FREE R VALUE : 0.2110 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 99 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1391 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 98 REMARK 3 SOLVENT ATOMS : 202 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.07000 REMARK 3 B22 (A**2) : -1.01000 REMARK 3 B33 (A**2) : 1.08000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.08 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.05 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.200 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.340 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.980 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.440 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.980 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.740 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.42 REMARK 3 BSOL : 47.38 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARA REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARA REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIGAND.PARAM REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : LIGAND.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 4NWK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JAN-14. REMARK 100 THE RCSB ID CODE IS RCSB083745.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-FEB-04 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 32-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26368 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.620 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 21.59850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.92600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.59850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.92600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -14 REMARK 465 LYS A -13 REMARK 465 LYS A -12 REMARK 465 LYS A -11 REMARK 465 THR A 178 REMARK 465 MET A 179 REMARK 465 ARG A 180 REMARK 465 SER A 181 REMARK 465 PRO A 182 REMARK 465 ALA A 183 REMARK 465 ILE A 184 REMARK 465 ARG A 185 REMARK 465 ALA A 186 REMARK 465 PRO A 187 REMARK 465 SER A 188 REMARK 465 THR A 189 REMARK 465 SER A 190 REMARK 465 LEU A 191 REMARK 465 ARG A 192 REMARK 465 PRO A 193 REMARK 465 HIS A 194 REMARK 465 SER A 195 REMARK 465 SER A 196 REMARK 465 THR A 197 REMARK 465 THR A 198 REMARK 465 THR A 199 REMARK 465 THR A 200 REMARK 465 THR A 201 REMARK 465 THR A 202 REMARK 465 GLU A 203 REMARK 465 ILE A 204

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 38 -168.71 -106.94 REMARK 500 REMARK 500 REMARK: NULL

REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 499 DISTANCE = 6.85 ANGSTROMS

REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 302 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 99 SG REMARK 620 2 CYS A 97 SG 125.2 REMARK 620 3 CYS A 145 SG 111.0 112.6 REMARK 620 N 1 2

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2R8 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 308 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 309 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 310

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4NWL RELATED DB: PDB

REMARK 999 REMARK 999 SEQUENCE REMARK 999 The cofactor 4A residues -10-0(GLY SER VAL VAL ILE VAL GLY ARG ILE REMARK 999 ASN LEU) in this entry correspond to residues numbering 1678-1688 REMARK 999 of database sequence reference (UNP A8DG50). This peptide is REMARK 999 covalently linked to the N-terminus of NS3 via LINKER (SER GLY ASP REMARK 999 THR). C1679S mutation was engineered to prevent disulfide REMARK 999 formation. The V1686I and I1687N were engineered to optimize the REMARK 999 linker between the cofactor 4A and NS3.

DBREF 4NWK A -10 0 UNP A8DG50 A8DG50_9HEPC 1678 1688 DBREF 4NWK A 5 182 UNP A8DG50 A8DG50_9HEPC 1035 1212

SEQADV 4NWK MET A -14 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK LYS A -13 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK LYS A -12 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK LYS A -11 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK SER A -9 UNP A8DG50 CYS 1679 SEE REMARK 999 SEQADV 4NWK ILE A -2 UNP A8DG50 VAL 1686 SEE REMARK 999 SEQADV 4NWK ASN A -1 UNP A8DG50 ILE 1687 SEE REMARK 999 SEQADV 4NWK SER A 1 UNP A8DG50 LINKER SEQADV 4NWK GLY A 2 UNP A8DG50 LINKER SEQADV 4NWK ASP A 3 UNP A8DG50 LINKER SEQADV 4NWK THR A 4 UNP A8DG50 LINKER SEQADV 4NWK GLU A 13 UNP A8DG50 LEU 1043 ENGINEERED MUTATION SEQADV 4NWK GLU A 14 UNP A8DG50 LEU 1044 ENGINEERED MUTATION SEQADV 4NWK GLN A 17 UNP A8DG50 ILE 1047 ENGINEERED MUTATION SEQADV 4NWK GLU A 18 UNP A8DG50 ILE 1048 ENGINEERED MUTATION SEQADV 4NWK GLN A 21 UNP A8DG50 LEU 1051 ENGINEERED MUTATION SEQADV 4NWK THR A 40 UNP A8DG50 ALA 1070 ENGINEERED MUTATION SEQADV 4NWK SER A 47 UNP A8DG50 CYS 1077 ENGINEERED MUTATION SEQADV 4NWK LEU A 52 UNP A8DG50 CYS 1082 ENGINEERED MUTATION SEQADV 4NWK THR A 72 UNP A8DG50 ILE 1102 ENGINEERED MUTATION SEQADV 4NWK GLN A 86 UNP A8DG50 PRO 1116 ENGINEERED MUTATION SEQADV 4NWK ALA A 183 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK ILE A 184 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK ARG A 185 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK ALA A 186 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK PRO A 187 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK SER A 188 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK THR A 189 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK SER A 190 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK LEU A 191 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK ARG A 192 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK PRO A 193 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK HIS A 194 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK SER A 195 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK SER A 196 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK THR A 197 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK THR A 198 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK THR A 199 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK THR A 200 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK THR A 201 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK THR A 202 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK GLU A 203 UNP A8DG50 EXPRESSION TAG SEQADV 4NWK ILE A 204 UNP A8DG50 EXPRESSION TAG

SEQRES 1 A 219 MET LYS LYS LYS GLY SER VAL VAL ILE VAL GLY ARG ILE SEQRES 2 A 219 ASN LEU SER GLY ASP THR ALA TYR ALA GLN GLN THR ARG SEQRES 3 A 219 GLY GLU GLU GLY CYS GLN GLU THR SER GLN THR GLY ARG SEQRES 4 A 219 ASP LYS ASN GLN VAL GLU GLY GLU VAL GLN ILE VAL SER SEQRES 5 A 219 THR ALA THR GLN THR PHE LEU ALA THR SER ILE ASN GLY SEQRES 6 A 219 VAL LEU TRP THR VAL TYR HIS GLY ALA GLY THR ARG THR SEQRES 7 A 219 ILE ALA SER PRO LYS GLY PRO VAL THR GLN MET TYR THR SEQRES 8 A 219 ASN VAL ASP LYS ASP LEU VAL GLY TRP GLN ALA PRO GLN SEQRES 9 A 219 GLY SER ARG SER LEU THR PRO CYS THR CYS GLY SER SER SEQRES 10 A 219 ASP LEU TYR LEU VAL THR ARG HIS ALA ASP VAL ILE PRO SEQRES 11 A 219 VAL ARG ARG ARG GLY ASP SER ARG GLY SER LEU LEU SER SEQRES 12 A 219 PRO ARG PRO ILE SER TYR LEU LYS GLY SER SER GLY GLY SEQRES 13 A 219 PRO LEU LEU CYS PRO ALA GLY HIS ALA VAL GLY ILE PHE SEQRES 14 A 219 ARG ALA ALA VAL CYS THR ARG GLY VAL ALA LYS ALA VAL SEQRES 15 A 219 ASP PHE ILE PRO VAL GLU SER LEU GLU THR THR MET ARG SEQRES 16 A 219 SER PRO ALA ILE ARG ALA PRO SER THR SER LEU ARG PRO SEQRES 17 A 219 HIS SER SER THR THR THR THR THR THR GLU ILE

HET 2R8 A 301 50 HET ZN A 302 1 HET SO4 A 303 5 HET GOL A 304 6 HET GOL A 305 6 HET GOL A 306 6 HET GOL A 307 6 HET GOL A 308 6 HET GOL A 309 6 HET GOL A 310 6

HETNAM 2R8 N-(TERT-BUTOXYCARBONYL)-3-METHYL-L-VALYL-(4R)-N-{(1R, HETNAM 2 2R8 2S)-1-[(CYCLOPROPYLSULFONYL)CARBAMOYL]-2- HETNAM 3 2R8 ETHENYLCYCLOPROPYL}-4-[(6-METHOXYISOQUINOLIN-1-YL) HETNAM 4 2R8 OXY]-L-PROLINAMIDE HETNAM ZN ZINC ION HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL

HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL

FORMUL 2 2R8 C35 H47 N5 O9 S FORMUL 3 ZN ZN 2+ FORMUL 4 SO4 O4 S 2- FORMUL 5 GOL 7(C3 H8 O3) FORMUL 12 HOH *202(H2 O)

HELIX 1 1 GLY A 12 GLY A 23 1 12 HELIX 2 2 TYR A 56 GLY A 60 1 5 HELIX 3 3 PRO A 131 LYS A 136 1 6 HELIX 4 4 GLU A 173 LEU A 175 5 3

SHEET 1 A 7 TYR A 6 GLN A 9 0 SHEET 2 A 7 VAL A -7 ASN A -1 -1 N ASN A -1 O TYR A 6 SHEET 3 A 7 VAL A 33 SER A 37 -1 O ILE A 35 N VAL A -5 SHEET 4 A 7 THR A 42 ILE A 48 -1 O ALA A 45 N GLN A 34 SHEET 5 A 7 VAL A 51 VAL A 55 -1 O TRP A 53 N THR A 46 SHEET 6 A 7 LEU A 82 GLN A 86 -1 O TRP A 85 N LEU A 52 SHEET 7 A 7 TYR A 75 ASN A 77 -1 N ASN A 77 O LEU A 82 SHEET 1 B 7 ASP A 103 VAL A 107 0 SHEET 2 B 7 VAL A 113 GLY A 120 -1 O VAL A 116 N LEU A 104 SHEET 3 B 7 ARG A 123 ARG A 130 -1 O ARG A 123 N ARG A 119 SHEET 4 B 7 VAL A 163 PRO A 171 -1 O VAL A 167 N GLY A 124 SHEET 5 B 7 ALA A 150 THR A 160 -1 N ALA A 156 O ASP A 168 SHEET 6 B 7 PRO A 142 LEU A 144 -1 N LEU A 143 O VAL A 151 SHEET 7 B 7 ASP A 103 VAL A 107 -1 N TYR A 105 O LEU A 144

LINK SG CYS A 99 ZN ZN A 302 1555 1555 2.18 LINK SG CYS A 97 ZN ZN A 302 1555 1555 2.27 LINK SG CYS A 145 ZN ZN A 302 1555 1555 2.38

SITE 1 AC1 25 GLN A 41 PHE A 43 HIS A 57 GLY A 58 SITE 2 AC1 25 ASP A 79 ASP A 81 HIS A 110 ASP A 112 SITE 3 AC1 25 ARG A 130 PRO A 131 ILE A 132 TYR A 134 SITE 4 AC1 25 LEU A 135 LYS A 136 GLY A 137 SER A 138 SITE 5 AC1 25 SER A 139 PHE A 154 ARG A 155 ALA A 156 SITE 6 AC1 25 ALA A 157 GOL A 305 GOL A 309 GOL A 310 SITE 7 AC1 25 HOH A 457 SITE 1 AC2 4 CYS A 97 CYS A 99 CYS A 145 HIS A 149 SITE 1 AC3 9 THR A 10 ARG A 11 GLY A 12 GLY A 15 SITE 2 AC3 9 ARG A 117 ARG A 119 HOH A 426 HOH A 450 SITE 3 AC3 9 HOH A 558 SITE 1 AC4 9 SER A 66 VAL A 71 GLN A 86 ALA A 87 SITE 2 AC4 9 PRO A 88 HOH A 417 HOH A 468 HOH A 476 SITE 3 AC4 9 HOH A 539 SITE 1 AC5 5 THR A 42 GLY A 137 2R8 A 301 GOL A 310 SITE 2 AC5 5 HOH A 458 SITE 1 AC6 9 GLY A 60 THR A 61 ARG A 62 PRO A 129 SITE 2 AC6 9 HOH A 437 HOH A 447 HOH A 469 HOH A 487 SITE 3 AC6 9 HOH A 494 SITE 1 AC7 5 THR A 22 GLY A 120 ASP A 121 SER A 122 SITE 2 AC7 5 HOH A 520 SITE 1 AC8 5 LEU A 0 GLY A 2 ASP A 3 ALA A 5 SITE 2 AC8 5 HOH A 547 SITE 1 AC9 6 SER A 133 TYR A 134 2R8 A 301 HOH A 432 SITE 2 AC9 6 HOH A 463 HOH A 561 SITE 1 BC1 9 GLN A 41 SER A 128 ARG A 130 LYS A 136 SITE 2 BC1 9 2R8 A 301 GOL A 305 HOH A 451 HOH A 457 SITE 3 BC1 9 HOH A 458

CRYST1 43.197 103.852 45.298 90.00 90.00 90.00 P 21 21 2 4

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.023150 0.000000 0.000000 0.00000

SCALE2 0.000000 0.009629 0.000000 0.00000

SCALE3 0.000000 0.000000 0.022076 0.00000